Literature DB >> 41545

Pharmacokinetics and metabolism of various benzodiazepines used as hypnotics.

D D Breimer.   

Abstract

1 In the management of insomnia with drugs, any action should be restricted to the duration of the night and residual effects should be absent during the day-time. The intermittent type of drug action desired is fundamentally different from drug treatment where a constant effect is sought. 2 Duration of drug action is dependent on the kinetics of distribution and elimination of the parent drug and its effective metabolites. In addition biopharmaceutical factors, such as those which promote a rapid rate of absorption, are important. 3 These considerations serve as a guide for a review of the kinetics and metabolism of various benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 41545      PMCID: PMC1429621          DOI: 10.1111/j.1365-2125.1979.tb00449.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

Review 1.  Clinical pharmacokinetics of hypnotics.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

2.  Flunitrazepam, an investigational hypnotic drug: sleep laboratory evaluations.

Authors:  E O Bixler; A Kales; C R Soldatos; J D Kales
Journal:  J Clin Pharmacol       Date:  1977-10       Impact factor: 3.126

3.  Bioavailability from various galenic formulations of flunitrazepam.

Authors:  J P Cano; M Soliva; D Hartmann; W H Ziegler; R Amrein
Journal:  Arzneimittelforschung       Date:  1977

4.  Plasma nitrazepam concentrations after an acute intake and their correlation to sedation and serum growth hormone levels.

Authors:  L Kangas; J Kanto; E Syvälahti
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-07

5.  Plasma levels and derived pharmacokinetic characteristics of unchanged nitrazepam in man.

Authors:  J Rieder
Journal:  Arzneimittelforschung       Date:  1973-02

6.  Clinical pharmacokinetics of lorazepam. II. Intramuscular injection.

Authors:  D J Greenblatt; T H Joyce; W H Comer; J A Knowles; R I Shader; A A Kyriakopoulos; D S MacLaughlin; H W Ruelius
Journal:  Clin Pharmacol Ther       Date:  1977-02       Impact factor: 6.875

7.  Pharmacokinetics of N-desmethyldiazepam in healthy volunteers after single daily doses of dipotassium chlorazepate.

Authors:  C Post; S Lindgren; A Bertler; H Malmgren
Journal:  Psychopharmacology (Berl)       Date:  1977-07-18       Impact factor: 4.530

8.  The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

Authors:  U Klotz; G R Avant; A Hoyumpa; S Schenker; G R Wilkinson
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

9.  Unchanged protein binding and the increase of serum diazepam levels after food intake.

Authors:  K Korttila; L Kangas
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-02

Review 10.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

View more
  20 in total

1.  Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.

Authors:  R Jochemsen; J G Wesselman; C J van Boxtel; J Hermans; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

2.  Clinical pharmacokinetics of hypnotic benzodiazepines: a summary.

Authors:  D D Breimer; R Jochemsen
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

3.  The use of short- and long-acting hypnotics in clinical medicine.

Authors:  A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

4.  Activity of the hypnotics, flunitrazepam and triazolam, in man.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

5.  Pharmacokinetics and pharmacodynamics following single and repeated nightly administrations of loprazolam, a new benzodiazepine hypnotic.

Authors:  G T McInnes; E A Bunting; R M Ings; J Robinson; S I Ankier
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

6.  Temazepam and the perceptual-motor performance of professional footballers.

Authors:  J Golby; M A Hutson
Journal:  Br J Sports Med       Date:  1985-06       Impact factor: 13.800

Review 7.  Pharmacological treatment of insomnia.

Authors:  M Maczaj
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

8.  Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold.

Authors:  C L Spinweber; L C Johnson
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 9.  Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

10.  Loprazolam (HR158) and flurazepam with ethanol compared on tests of psychomotor ability.

Authors:  I Hindmarch; A C Gudgeon
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.